Lamivudine and Zidovudine

Product NDC

43063-346

11-digit product format

430630346

Labeler code

43063

Product ID

43063-346_7cc4b57a-b4bf-9a51-e053-2a91aa0a0483

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Lamivudine and Zidovudine

Dosage form

TABLET, FILM COATED

Route

ORAL

Labeler

PD-Rx Pharmaceuticals, Inc.

Application

ANDA079081

Marketing category

ANDA

Marketing start

2011-12-27

Marketing end

0000-00-00

Substance

LAMIVUDINE; ZIDOVUDINE

Active strength

150 mg/1; mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]

NDC exclude flag

No

Listing certified through

2019-12-31

Current FDA listing

Historical FDA.report record